- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
23rd World Congress of Dermatology Accepts Miraculins Scientific Poster
Miraculins Inc. (TSXV:MOM) reported that the 23rd World Congress of Dermatology accepted a scientific poster from a collaboration between Miraculins and Amway Corporation’s Open Innovation Team. The poster concludes that advanced glycation end-products (AGE) as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, with vitamin supplementation associated with lower skin AGEs.
The poster concludes that advanced glycation end-products (AGE) as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, with vitamin supplementation associated with lower skin AGEs. The collaborative story described was conducted in the US, on 555 women between 16 to 82 years old, assessed through a cross-sectional survey. The subjects’ skin AGE’s were measured utilizing the Scout DS® device, and facial wrinkling and skin lightness were measured using standardized facial photography and analysis.
As quoted in the press release:
The poster, entitled “The Association of Skin Glycation with Facial Skin Aging”, concludes that advanced glycation end-products (“AGEs”) – as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, and that vitamin supplementation was associated with lower skin AGEs. Miraculins has been reviewing these important pilot findings with Amway to determine the potential next steps in assessing the viability of Scout DS® intellectual property being utilized in a device specifically for the health and beauty segment.
The collaborative study was conducted in the United States on 555 women between the ages of 16 and 82, and was comprised of a mixed race cohort. Subjects were assessed through a cross-sectional survey using objective methods and a questionnaire that took into account age, ethnicity, BMI, smoking, sun protection habits, years working outdoors, vitamin supplementation, skin care habits, tanning, history of type 1 or 2 diabetes, kidney, heart and skin disease. Skin AGE’s were measured utilizing the Scout DS® device, and facial wrinkling and skin lightness were measured using standardized facial photography and analysis.
Click here to read the Miraculins Inc. (TSXV:MOM) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.